Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus F Neurath

Showing results (71-80 of 775) with videos related to

Pageof 78
Sort By:
The Lancet. Oncology|January 14, 2022
Is non-invasive Cytosponge the holy grail for Barrett's neoplasia?Michael Vieth, Markus F Neurath
Cellular and Molecular Gastroenterology and Hepatology|November 6, 2021
Deciphering Novel Mechanistic and Pharmacokinetic Effects of Tofacitinib in Intestinal Inflammation: Expect the UnexpectedRaja Atreya, Markus F Neurath
Gastroenterology Clinics of North America|September 6, 2006
Chromoendoscopy and other novel imaging techniquesRalf Kiesslich, Markus F Neurath
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 14, 2005
Endoscopic confocal imagingRalf Kiesslich, Markus F Neurath
Immunological Reviews|June 29, 2017
Pathogenic T cell subsets in allergic and chronic inflammatory bowel disordersSebastian Zundler, Markus F Neurath
Zeitschrift Fur Gastroenterologie|May 13, 2017
Christoph Becker, Markus F Neurath
Cytokine & Growth Factor Reviews|March 8, 2011
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancerMarkus F Neurath, Susetta Finotto
Nature Communications|August 17, 2018
Resolution of chronic inflammatory disease: universal and tissue-specific conceptsGeorg Schett, Markus F Neurath
Therapeutic Advances in Gastroenterology|October 21, 2017
Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challengesMarcel Vetter, Markus F Neurath
Gastrointestinal Endoscopy|September 20, 2015
Advances in detection and management of dysplasia in inflammatory bowel disease: Is endoscopic submucosal dissection ready for prime time in inflammatory bowel disease?Ralf Kiesslich, Markus F Neurath
Pageof 78

Showing results (71-80 of 775) with videos related to

Sort By:
Pageof 78
The Lancet. Oncology|January 14, 2022
Is non-invasive Cytosponge the holy grail for Barrett's neoplasia?Michael Vieth, Markus F Neurath
Cellular and Molecular Gastroenterology and Hepatology|November 6, 2021
Deciphering Novel Mechanistic and Pharmacokinetic Effects of Tofacitinib in Intestinal Inflammation: Expect the UnexpectedRaja Atreya, Markus F Neurath
Gastroenterology Clinics of North America|September 6, 2006
Chromoendoscopy and other novel imaging techniquesRalf Kiesslich, Markus F Neurath
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 14, 2005
Endoscopic confocal imagingRalf Kiesslich, Markus F Neurath
Immunological Reviews|June 29, 2017
Pathogenic T cell subsets in allergic and chronic inflammatory bowel disordersSebastian Zundler, Markus F Neurath
Zeitschrift Fur Gastroenterologie|May 13, 2017
Christoph Becker, Markus F Neurath
Cytokine & Growth Factor Reviews|March 8, 2011
IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancerMarkus F Neurath, Susetta Finotto
Nature Communications|August 17, 2018
Resolution of chronic inflammatory disease: universal and tissue-specific conceptsGeorg Schett, Markus F Neurath
Therapeutic Advances in Gastroenterology|October 21, 2017
Emerging oral targeted therapies in inflammatory bowel diseases: opportunities and challengesMarcel Vetter, Markus F Neurath
Gastrointestinal Endoscopy|September 20, 2015
Advances in detection and management of dysplasia in inflammatory bowel disease: Is endoscopic submucosal dissection ready for prime time in inflammatory bowel disease?Ralf Kiesslich, Markus F Neurath
Pageof 78